4/A
Changes in Ownership
Intellia Therapeutics, Inc. Filed Acc 0001209191-22-016535
Options or other derivatives
- EVP, Chief Financial Officer acquired 18,600 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Goddard Glenn · EVP, Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-03-01 | Grant or award : show line 1 in the form Stock Option (right to buy) | +18,600 | 18,600 | D |
Loading xslF345X03/doc4a.xml…